MIPS Home MIPS General Information MIPS Grants MIPS Courses MIPS Research MIPS Software MIPS Web Tools MIPS Sitemap
About MIPS MIPS News Faculty & Staff Recent Pubs Directions Facilities Events & Meetings Employment Associated Depts Useful Links
Grant News CCNE-TR CVIS ICMIC ICBP NTROI SMIS
BIOE222 Pharmacokinetics Stats & Data Analysis
BIOE222A F2009 BIOE222B W2009 BIOE222A F2008 BIOE222B W2008 BIOE222A F2007 BIOE222B W2007 BIOE222 F2006 BIOE222 F2005 BIOE222 F2004
Biswal Lab Blankenberg Lab Cheng Lab Contag Lab Felsher Lab Gambhir Lab Graves Lab Guccione Lab Levin Lab Lin Lab McConnell Moseley Lab Paik Lab Plevritis Lab Ramasamy Lab Rao Lab Rutt Lab Schnitzer Lab Vasanawala Lab Willmann Lab Wu Lab Xing Lab
NCIL MRSRL
AMIDE
NucMed Mediabook PET Brain Atlas PET-FDG Whole Body Atlas




CCNE Home

Nanobiotechnology Seminar

Annual Symposium

CCNE News

Faculty

Postdocs
Graduate Students

Scientific Papers

Corporate Collaboration

Private Foundations

Projects

Core Resources

Pilot Projects

Leadership & Organization

Environment

Links

Employment Opportunities


Center for Cancer Nanotechnology Excellence Focused on Therapy Response

Faculty

Anjali Jain, Ph.D.
Co-Investigator: Project 4
Cedars-Sinai Medical Center
Louis Warschaw Prostate Cancer Center
8631 West Third Street, Suite 1001E
Los Angeles, CA 90048
Phone: 310-423-7600
Fax: 310-423-1998
Email: jaina@cshs.org


Investigator: Project 4, Assistant Professor in Hematology/Oncology (Cedars-Sinai; UCLA)
Dr. Jain is an Adjunct Assistant Professor in Hematology/Oncology at the University of California, Los Angeles and a Research Scientist at the Cedars-Sinai Medical Center, Los Angeles. Her work involves basic molecular understanding of the HER-kinase axis as it relates to androgen-independent prostate cancer progression i.e., the cross-talk of HER-kinase axis with the androgen receptor signaling pathway. It involves the use of novel therapeutics that target distinct members of the signaling axis in various prostate cancer xenograft. These studies focus on understanding the mechanisms of action and resistance of these drugs and identifying biomarkers for their activity.

[ Back ]
crumpnews events